The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol

Author: Rainczuk A.   Smooker P.M.   Kedzierski L.   Black C.G.   Coppel R.L.   Spithill T.W.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.21, Iss.21, 2003-06, pp. : 3030-3042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content